Goldman Sachs
USNA icon

Goldman Sachs’s Usana Health Sciences USNA Stock Holding History

Goldman Sachs’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-45,000
Closed -$1.95M – 6804
2013
Q3 		$1.95M Buy
+45,000
New +$1.81M ﹤0.01% 3940

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's USNA Position: Q1 2026 in Review

Goldman Sachs reduced its Usana Health Sciences (USNA) stake by 1.2% in Q1 2026, selling an estimated $22.5K and leaving 91,149 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #4733.

Goldman Sachs first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.3M in Q2 2018. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Goldman Sachs held 91,149 shares of Usana Health Sciences worth $1.59M as of Q1 2026.
  • Goldman Sachs sold 1,134 Usana Health Sciences shares in Q1 2026, an estimated $22.5K.
  • Usana Health Sciences made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4733 holding.
  • Goldman Sachs first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Usana Health Sciences position peaked at $22.3M in Q2 2018.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.